Results 251 to 260 of about 114,761 (352)

Gamma interferon induces different keratinocyte cellular patterns of expression of HLA-DR and DQ and intercellular adhesion molecule-I (ICAM-I) antigens

, 1989
C.E.M. Griffiths, John J. Voorhees, B J Nickoloff   +2 more
openalex   +2 more sources

Effects of Vemurafenib ± Cobimetinib on Intratumoral and Host Immunity in Patients With BRAFV600 Mutant Melanoma: Implications for Combination With Immunotherapy

Cancer Medicine, Volume 15, Issue 1, January 2026.
We evaluated sequential tumor biopsies during therapy to test the hypotheses that BRAF/MEKi would increase TIL and lead to an expansion of functional intratumoral tumor‐reactive CD8 T‐cells and TIL clonality in the tumor microenvironment. Data from this study provides provocative evidence that, while BRAF+/−MEK inhibitor therapy produces an increase in
Suthee Rapisuwon, Craig L. Slingluff Jr., Jennifer A. Wargo, Ryan J. Sullivan, Benjamin Izar, Jia‐Ren Lin, Ileana S. Mauldin, Walter C. Olson, Christine A. Tran, Gabrielle H. Schwartzman, Geoffrey T. Gibney, Waddah Al‐Refaie, Michael B. Atkins   +12 more
wiley   +1 more source

Toward next-generation therapeutic HPV vaccines: A review on expanding the antigen repertoire and an integrated bioinformatics selection framework. [PDF]

Hum Vaccin Immunother
Zhang D, Guo S, Yuan J, Hu Y, Li K, Han Y.   +5 more
europepmc   +1 more source

T Cell/Mast Cell Crosstalk in the Skin of Patients Suffering From Immune‐Mediated Diseases, Focusing on Chronic Spontaneous Urticaria

Clinical and Translational Allergy, Volume 16, Issue 1, January 2026.
ABSTRACT The crosstalk between immune cells in skin lesions of numerous immune‐mediated diseases such as atopic dermatitis, psoriasis and other T cell mediated is fundamental for understanding the pathogenesis and treating these diseases. The mechanisms by which most activated immune cells such as T cells, mast cells, and neutrophils are shifted from ...
Elias Toubi, Raeda Mubariki, Zahava Vadasz   +2 more
wiley   +1 more source

Enhancing Tuberculosis Diagnosis and Treatment Monitoring: Evaluating Ki67 and HLA-DR Biomarkers Via Point-of-Care Testing and Comparative Analysis of Flow Cytometry Versus ELISA in Whole Blood Samples.

J Pharm Bioallied Sci
Ilyas M, Singh A, Gupta PP, Saad T, Singh P, Mishra S, Asati A.   +6 more
europepmc   +1 more source

Differential Alloreactivity: Lessons Learned From a Singular HLA Locus. [PDF]

HLA
Arrieta-Bolaños E.
europepmc   +1 more source

Generation of effector cells from T cell subsets [PDF]

, 1979
Koszinowski, Ulrich H., Simon, M. M.
core  

Analysis of human T-cell epitopes in the 19,000 MW antigen of Mycobacterium tuberculosis: influence of HLA-DR.

, 1991
A. Faith, Carlos Álvarez, Raju Lathigra, Eva Román, M. Fernández, Sara Brett, David M. Mitchell, J Iványi, A. D. M. Rees   +8 more
openalex   +1 more source

Circulating HLA-DR+ natural killer cells have potent lytic ability and weak antigen-presenting cell function

, 2008
Bryan M. Burt, George Plitas, Hoang M. Nguyen, Jennifer Stableford, Zubin M. Bamboat, Ronald P. DeMatteo   +5 more
openalex   +2 more sources

UGT1A1 and Sacituzumab Govitecan Toxicity: A Systematic Review and Meta‐Analysis

Clinical Pharmacology &Therapeutics, Volume 119, Issue 1, Page 63-73, January 2026.
Sacituzumab govitecan (SG), a humanized antibody‐drug conjugate, enables intra‐tumor delivery of SN‐38, the active metabolite of irinotecan, with the aim of increasing efficacy. SN‐38 is predominantly inactivated by the polymorphically expressed uridine diphosphate glucuronosyltransferase 1A1 (UGT1AA) where reduced activity can lead to toxicity.
Cinzia Dello Russo, Innocent Gerald Asiimwe, Sudeep Pushpakom, Carlo Palmieri, Munir Pirmohamed   +4 more
wiley   +1 more source